Arcutis Biotherapeutics (ARQT) Asset Utilization Ratio (2022 - 2026)

Arcutis Biotherapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.93 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 54.46% year-over-year to 0.93; the TTM figure through Mar 2026 stood at 0.93 (up 54.46% YoY), while the FY2025 annual figure was 0.96, up 99.35% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.93, roughly flat from 0.93 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.93 in Q1 2026, with the low at 0.0 in Q3 2022.
• The 5-year median for Asset Utilization Ratio is 0.29 (2024), against an average of 0.39.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio surged 8745.41% in 2023, then soared 49.95% in 2024.
• Arcutis Biotherapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then surged by 3572.16% to 0.28 in 2023, then jumped by 49.95% to 0.42 in 2024, then jumped by 119.66% to 0.93 in 2025, then climbed by 0.03% to 0.93 in 2026.
• Business Quant data shows ARQT's Asset Utilization Ratio at 0.93 in Q1 2026, 0.93 in Q4 2025, and 0.87 in Q3 2025.